Clinical Focus

  • Anesthesia

Academic Appointments

Administrative Appointments

  • Co-Director of Global Resident Pathway, Department of Anesthesiology, Stanford University (2019 - Present)
  • Co-Director of Division of Global Health Equity, Department of Anesthesiology, Stanford University (2020 - Present)

Honors & Awards

  • Faculty Fellow, Center for Innovation in Global Health (CIGH) Stanford University

Professional Education

  • Board Certification: American Board of Anesthesiology, Anesthesia (2019)
  • Fellowship: Stanford University Anesthesiology Fellowships (2019) CA
  • Fellowship, Stanford University, Global Anesthesiology (2019)
  • Board Certification, American Board of Anesthesiology, Anesthesia (2019)
  • Residency: Loyola University Medical Center Anesthesiology Residency (2018) IL
  • Medical Education: Loyola University Stritch School of Medicine (2014) IL

All Publications

  • Hands Across the Water: Global Health and International Medical Outreach ASA Monitor Deutch, Z., Strowd, S. M. 2022; 86: 20-21
  • Creating a Resident Pathway to Prepare Residents for International Teaching Electives Strowd, S., Duperrault, M. LIPPINCOTT WILLIAMS & WILKINS. 2021: 784
  • The Oxford Specialist Handbook of Global Anaesthesia (Book Review) ANESTHESIOLOGY Book Review Authored by: Strowd, S. M. 2021; 135 (1): 194
  • Negotiating for Success Cheng, T., Nabipour, S., Strowd, S., Wald, S. ASA Monitor. 2021
  • Malignant Hyperthermia Versus Thyroid Storm in a Patient With Symptomatic Graves Disease: A Case Report A & A PRACTICE Strowd, S. M., Majewski, M. B., Asteris, J. 2018; 10 (5): 97-99


    Malignant hyperthermia and thyroid storm are intraoperative emergencies with overlapping symptoms but different treatment protocols. We faced this diagnostic dilemma in a 25-year-old patient with symptomatic hyperthyroidism, elevated free T3 and free T4, and low thyroid-stimulating hormone from Graves disease despite treatment with propranolol 80 mg daily and methimazole 40 mg every 8 hours. During thyroidectomy, he developed hyperthermia and hypercarbia without tachycardia. When the rate of rise of PaCO2 and temperature accelerated, we treated the patient for malignant hyperthermia, a diagnosis subsequently confirmed by genetic testing.

    View details for DOI 10.1213/XAA.0000000000000639

    View details for Web of Science ID 000426548100001

    View details for PubMedID 29028638